Related Research Articles
Papua New Guinea, officially the Independent State of Papua New Guinea, is a country in Oceania that comprises the eastern half of the island of New Guinea and its offshore islands in Melanesia. Its capital, located along its southeastern coast, is Port Moresby. It is the world's third largest island country with an area of 462,840 km2 (178,700 sq mi).
A United States Adopted Name (USAN) is a unique nonproprietary name assigned to a medication marketed in the United States. Each name is assigned by the USAN Council, which is co-sponsored by the American Medical Association (AMA), the United States Pharmacopeial Convention (USP), and the American Pharmacists Association (APhA).
Usan-guk, or the State of Usan, occupied Ulleung-do and the adjacent islands during the Korean Three Kingdoms period. According to the Samguk Sagi, it was conquered by the Silla general Kim Isabu in 512. He is said to have used wooden lions or tigers to intimidate the residents into surrendering. It has been written that the alias of Usan-guk is Ulleung-do. Usan-guk rarely entered into historical records, but appears to have continued a largely autonomous existence until its annexation to Goryeo in 930.
Dimethyltubocurarinium chloride is a non-depolarizing nicotinic acetylcholine receptor antagonist used as a muscle relaxant.
Etybenzatropine (INN), also known as ethybenztropine and tropethydrylin, is an anticholinergic/antihistamine marketed under the trade names Panolid, Ponalid, and Ponalide, which is used as an antiparkinsonian agent. Like its analogue benzatropine, it may act as a dopamine reuptake inhibitor.
The Numugen (Numagen) languages are a small family of closely related languages in the Madang branch of the Trans–New Guinea languages (TNG) phylum of New Guinea, spoken in the region of the Numagen River.
Sirukumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).
Mefexamide, also known as mefexadyne and mexephenamide, is a central nervous system stimulant that is no longer marketed.
Vixotrigine, formerly known as raxatrigine, is an analgesic which is under development by Convergence Pharmaceuticals for the treatment of lumbosacral radiculopathy (sciatica) and trigeminal neuralgia (TGN). Vixotrigine was originally claimed to be a selective central Nav1.3 blocker, but was subsequently redefined as a selective peripheral Nav1.7 blocker. Following this, vixotrigine was redefined once again, as a non-selective voltage-gated sodium channel blocker. As of January 2018, it is in phase III clinical trials for trigeminal neuralgia and is in phase II clinical studies for erythromelalgia and neuropathic pain. It was previously under investigation for the treatment of bipolar disorder, but development for this indication was discontinued.
Roflurane is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.
Haloprogesterone, sold under the brand name Prohalone, is a progestin medication which was previously marketed by Ayerst but is now no longer available.
Tigestol, also known as 17α-ethynylestr-5(10)-en-17β-ol, is a steroidal progestin of the 19-nortestosterone group that was developed by Organon in the 1960s but was never marketed. It is an isomer of the related 19-nortestosterone derivative progestins lynestrenol and cingestol.
Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.
Gerard P. Reesink is a Dutch linguist who specializes in Papuan languages.
References
- ↑ Usan at Ethnologue (18th ed., 2015)